Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease

Phytochemistry. 2022 Jan:193:112984. doi: 10.1016/j.phytochem.2021.112984. Epub 2021 Oct 12.

Abstract

Papain-like protease (PLpro) is a key enzyme encoded by SARS-CoV-2 that is essential for viral replication and immune evasion. Significant suppression of viral spread and promotion of antiviral immunity can be achieved by inhibition of PLpro, revealing an inspiring strategy for COVID-19 treatment. This study aimed to discover PLpro inhibitors by investigating the national compound library of traditional Chinese medicines (NCLTCMs), a phytochemical library comprising over 9000 TCM-derived compounds. Through virtual screening and enzymatic evaluations, nine natural biflavones were confirmed to be effective PLpro inhibitors with IC50 values ranging from 9.5 to 43.2 μM. Pro-ISG15 cleavage assays further demonstrated that several biflavones exhibited potent inhibitory effects against PLpro-mediated deISGylation, a key process involved in viral immune evasion. Herein, we report the discovery, antiviral evaluation, structure-activity relationship elucidation and molecular docking investigation of biflavones as potent inhibitors of SARS-CoV-2 PLpro.

Keywords: Antiviral; Natural biflavone; Papain-like protease; SARS-CoV-2; deISGylation.

MeSH terms

  • Antiviral Agents / pharmacology
  • COVID-19 Drug Treatment*
  • Coronavirus Papain-Like Proteases
  • Humans
  • Molecular Docking Simulation
  • Protease Inhibitors / pharmacology
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Protease Inhibitors
  • Coronavirus Papain-Like Proteases
  • papain-like protease, SARS-CoV-2